Senior Director, Regulatory Affairs CMC

Beeline Medicines
•$242,000 - $313,500•Remote

About The Position

The Senior Director, Regulatory Affairs CMC provides senior-level scientific and strategic regulatory leadership for Chemistry, Manufacturing, and Controls (CMC) activities across Beeline Medicines’ immunology and inflammation portfolio. The role develops and executes small-molecule CMC regulatory strategies from early clinical development through NDA filing and post-approval lifecycle management, and serves as the company’s primary authority on small-molecule CMC regulatory science. The Senior Director partners with Technical Development, Process Chemistry, Analytical Sciences, Quality, and external contract manufacturing organizations (CMOs) to ensure CMC programs and submissions align with FDA, EMA, ICH, and other global Health Authority expectations. As a senior member of Regulatory Affairs, the role also contributes to broader regulatory strategy and helps shape the company’s regulatory infrastructure. This position is designated as remote, with periodic travel to Beeline Medicines’ offices for in-person collaboration, team engagement, and business operations. Visit frequency and scheduling are determined by the company based on business needs.

Requirements

  • At least 12 years of CMC regulatory affairs experience in the pharmaceutical or biotechnology industry; this experience level is stated as preferred.
  • Hands-on small-molecule CMC regulatory experience is required.
  • Deep expertise in small-molecule CMC strategy, including API synthesis and control, drug-product formulation and manufacturing, and analytical method development and validation for oral, parenteral, and other dosage forms.
  • Extensive experience authoring and overseeing small-molecule CMC sections of global submissions, including INDs/CTAs, NDAs, MAAs, and post-approval supplements and variations in ICH CTD/eCTD format.
  • Demonstrated record of leading FDA and EMA CMC-focused Health Authority meetings, preparing briefing documents, and managing written responses to CMC deficiency letters.
  • Comprehensive knowledge of ICH Q8, Q9, Q10, Q11, and Q12; FDA small-molecule CMC guidance, including SUPAC, process validation, and container closure; and applicable EMA quality guidance.
  • Experience managing CMC regulatory aspects of technology transfer, new CMO qualification, and site-change filing strategies for small-molecule programs.
  • Strong knowledge of post-approval CMC change management regulations, including SUPAC categories, PAS/CBE filing requirements, and ex-U.S. variation frameworks.
  • Ability to lead and develop cross-functional teams in fast-paced, resource-constrained biotech or pharmaceutical environments and foster accountability, inclusion, and continuous learning.
  • Ability to influence across organizational boundaries, align senior stakeholders, and build consensus on complex regulatory or scientific priorities.
  • Ability to navigate ambiguity and organizational change, define structure and priorities, and scale functional capabilities as corporate strategy evolves.
  • Exceptional written and verbal communication skills, including the ability to explain complex regulatory, scientific, and operational matters to executives, Health Authorities, and cross-functional partners.
  • Skill in preparing and delivering presentations, briefing documents, and strategic updates to cross-functional leadership, board-level stakeholders, and external agencies.
  • Ability to facilitate productive dialogue in high-stakes meetings and collaborations while balancing clarity, diplomacy, and scientific precision.

Nice To Haves

  • An advanced degree (PhD, MS, or PharmD) in organic chemistry, pharmaceutical sciences, analytical chemistry, or a related small-molecule-relevant discipline is strongly preferred.
  • CMC regulatory strategy experience with biologics, such as monoclonal antibodies or recombinant proteins, is highly preferred but not required.

Responsibilities

  • Develop and lead CMC regulatory strategies for small-molecule assets from IND/CTA through NDA filing, post-approval lifecycle management, and drug-substance and drug-product labeling strategy.
  • Author, review, and oversee CMC sections of global submissions in ICH CTD format, including INDs, CTAs, NDAs, MAAs, Type II variations, and supplements; ensure quality, completeness, and regulatory defensibility.
  • Serve as the primary regulatory authority and strategic partner to Technical Development, Process Chemistry, Analytical Development, Formulation Sciences, and Quality on small-molecule CMC matters.
  • Lead Health Authority interactions on small-molecule CMC topics, including FDA Type B and Type C meetings, EMA Scientific Advice meetings, and responses to deficiency letters and information requests.
  • Interpret FDA, EMA, and ICH CMC guidance and advise development teams on design space, process validation, and control strategy regulatory acceptability.
  • Lead post-approval CMC change management strategies, including SUPAC assessments, Prior Approval Supplements, Changes Being Effected filings, and ex-U.S. variations.
  • Oversee regulatory aspects of small-molecule technology transfers, new CMO onboarding, site-to-site comparability, and related filing updates.
  • Establish and maintain small-molecule CMC regulatory SOPs, templates, and document workflows that support ICH CTD, eCTD, and electronic submission requirements.
  • Contribute CMC regulatory risk assessments and readiness analyses for small-molecule licensing candidates and acquisition targets.
  • Track CMC regulatory deliverables and submission timelines, identify dependencies and risks, and keep cross-functional teams aligned and submission-ready.
  • Partner closely with the CMC team and colleagues in Process Development, Analytical, Manufacturing Sciences, Drug Supply, and Quality; translate regulatory strategy into practical guidance for program decisions.
  • Take ownership of CMC regulatory responsibilities by proactively seeking information, building relationships, and removing barriers through initiative and resourcefulness.
  • Perform other duties and responsibilities as assigned.

Benefits

  • A comprehensive benefits package tailored to the country or region of hire, in compliance with local laws and practices.
  • Competitive health and wellness coverage; structure and premiums vary by country.
  • Paid time off, public holidays, and additional leave entitlements in accordance with local requirements.
  • Flexible work arrangements or hybrid schedule; availability varies by location and eligibility.
  • A discretionary annual bonus and long-term incentive award, such as equity, may be available based on individual and company performance.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service